Geoff Pardo

Mr. Pardo joined Gilde Healthcare Partners in 2011 as a Partner and has led investments in Inari Medical, Axonics Modulation Technologies (NASDAQ: AXNX), CVRx, Ablative Solutions, Inc., Inova Labs (sold to Resmed, Inc.), BionX (sold to Ottobock) and Vapotherm (NYSE: VAPO). He is currently a member of the Board of Directors at Inari, Axonics, Ablative Solutions, CVRx, and Vapotherm. Mr. Pardo also served as President & CEO of Facet Solutions, a spinal implant company focused on treating lumbar spinal stenosis until the company was sold to Globus Medical in 2011. Mr. Pardo began his career in medical devices as a product manager with Synthes USA (now J&J Depuy Synthes). Geoff has a B.A. from Brown University and an M.B.A. from the Wharton School of Business.